Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers

This study has been terminated.
(Interruption of business relations between Study Sponsor and Device Manufacturer)
Sponsor:
Information provided by:
Organogenesis
ClinicalTrials.gov Identifier:
NCT00512538
First received: August 3, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2002
  Estimated Primary Completion Date: No date given